<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34043194</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>08</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>08</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1940-6029</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>2322</Volume>
            <PubDate>
              <Year>2021</Year>
            </PubDate>
          </JournalIssue>
          <Title>Methods in molecular biology (Clifton, N.J.)</Title>
          <ISOAbbreviation>Methods Mol Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Differentiation of Midbrain Dopaminergic Neurons from Human iPS Cells.</ArticleTitle>
        <Pagination>
          <StartPage>73</StartPage>
          <EndPage>80</EndPage>
          <MedlinePgn>73-80</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-0716-1495-2_8</ELocationID>
        <Abstract>
          <AbstractText>Human-induced pluripotent stem (iPS) cells provide a powerful means for analyzing disease mechanisms and drug screening, especially for neurological diseases, considering the difficulty to obtain live pathological tissue. The midbrain dopaminergic neurons of the substantia nigra are mainly affected in Parkinson's disease, but it is impossible to obtain and analyze viable dopaminergic neurons from live patients. This problem can be overcome by the induction of dopaminergic neurons from human iPS cells. Here, we describe an efficient method for differentiating human iPS cells into midbrain dopaminergic neurons. This protocol holds merit for obtaining a deeper understanding of the disease and for developing novel treatments.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ishikawa</LastName>
            <ForeName>Kei-Ichi</ForeName>
            <Initials>KI</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan. kishikaw@juntendo.ac.jp.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Genomic and Regenerative Medicine, Juntendo University School of Medicine, Tokyo, Japan. kishikaw@juntendo.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nonaka</LastName>
            <ForeName>Risa</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Genomic and Regenerative Medicine, Juntendo University School of Medicine, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Akamatsu</LastName>
            <ForeName>Wado</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genomic and Regenerative Medicine, Juntendo University School of Medicine, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Methods Mol Biol</MedlineTA>
        <NlmUniqueID>9214969</NlmUniqueID>
        <ISSNLinking>1064-3745</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008636" MajorTopicYN="N">Mesencephalon</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013378" MajorTopicYN="N">Substantia Nigra</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Dopaminergic neurons</Keyword>
        <Keyword MajorTopicYN="Y">Induced pluripotent stem cells</Keyword>
        <Keyword MajorTopicYN="Y">Parkinson’s disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>27</Day>
          <Hour>12</Hour>
          <Minute>41</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34043194</ArticleId>
        <ArticleId IdType="doi">10.1007/978-1-0716-1495-2_8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676. https://doi.org/10.1016/j.cell.2006.07.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2006.07.024</ArticleId>
            <ArticleId IdType="pubmed">16904174</ArticleId>
            <ArticleId IdType="pmc">16904174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872. https://doi.org/10.1016/J.CELL.2007.11.019</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/J.CELL.2007.11.019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920. https://doi.org/10.1126/science.1151526</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1151526</ArticleId>
            <ArticleId IdType="pubmed">18029452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Y, Inoue H, Wu JC, Yamanaka S (2017) Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov 16:115–130</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd.2016.245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okita K, Yamakawa T, Matsumura Y et al (2013) An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31:458–466. https://doi.org/10.1002/stem.1293</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.1293</ArticleId>
            <ArticleId IdType="pubmed">23193063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumoto T, Fujimori K, Andoh-Noda T et al (2016) Functional neurons generated from T cell-derived induced pluripotent stem cells for neurological disease modeling. Stem Cell Reports 6:422–435. https://doi.org/10.1016/j.stemcr.2016.01.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stemcr.2016.01.010</ArticleId>
            <ArticleId IdType="pubmed">26905201</ArticleId>
            <ArticleId IdType="pmc">4788773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park IH, Arora N, Huo H et al (2008) Disease-specific induced pluripotent stem cells. Cell 134:877–886. https://doi.org/10.1016/j.cell.2008.07.041</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2008.07.041</ArticleId>
            <ArticleId IdType="pubmed">18691744</ArticleId>
            <ArticleId IdType="pmc">2633781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen HN, Byers B, Cord B et al (2011) LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8:267–280. https://doi.org/10.1016/j.stem.2011.01.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2011.01.013</ArticleId>
            <ArticleId IdType="pubmed">21362567</ArticleId>
            <ArticleId IdType="pmc">3578553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seibler P, Graziotto J, Jeong H et al (2011) Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 iPS cells. J Neurosci 31:5970–5976. https://doi.org/10.1523/JNEUROSCI.4441-10.2011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4441-10.2011</ArticleId>
            <ArticleId IdType="pubmed">21508222</ArticleId>
            <ArticleId IdType="pmc">3091622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Byers B, Cord B, Nguyen HN et al (2011) SNCA triplication Parkinson’s patient’s iPSC-derived DA neurons accumulate α-Synuclein and are susceptible to oxidative stress. PLoS One 6(11):e26159. https://doi.org/10.1371/journal.pone.0026159</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0026159</ArticleId>
            <ArticleId IdType="pubmed">22110584</ArticleId>
            <ArticleId IdType="pmc">3217921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imaizumi Y, Okada Y, Akamatsu W et al (2012) Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain 5:35. https://doi.org/10.1186/1756-6606-5-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1756-6606-5-35</ArticleId>
            <ArticleId IdType="pubmed">23039195</ArticleId>
            <ArticleId IdType="pmc">3546866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishikawa K-I, Yamaguchi A, Okano H, Akamatsu W (2018) Assessment of mitophagy in iPS cell-derived neurons. Methods Mol Biol 1759:59–67. https://doi.org/10.1007/7651_2017_10</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/7651_2017_10</ArticleId>
            <ArticleId IdType="pubmed">28324490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chambers SM, Fasano CA, Papapetrou EP et al (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27:275–280. https://doi.org/10.1038/nbt.1529</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nbt.1529</ArticleId>
            <ArticleId IdType="pubmed">19252484</ArticleId>
            <ArticleId IdType="pmc">2756723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujimori K, Matsumoto T, Kisa F et al (2017) Escape from pluripotency via inhibition of TGF-β/BMP and activation of Wnt signaling accelerates differentiation and aging in hPSC progeny cells. Stem Cell Reports 9:1675–1691. https://doi.org/10.1016/j.stemcr.2017.09.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stemcr.2017.09.024</ArticleId>
            <ArticleId IdType="pubmed">29107593</ArticleId>
            <ArticleId IdType="pmc">5831048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fasano CA, Chambers SM, Lee G et al (2010) Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell 6:336–347. https://doi.org/10.1016/j.stem.2010.03.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2010.03.001</ArticleId>
            <ArticleId IdType="pubmed">20362538</ArticleId>
            <ArticleId IdType="pmc">4336800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kriks S, Shim J-W, Piao J et al (2011) Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature 480:547–551. https://doi.org/10.1038/nature10648</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10648</ArticleId>
            <ArticleId IdType="pubmed">3245796</ArticleId>
            <ArticleId IdType="pmc">3245796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doi D, Samata B, Katsukawa M et al (2014) Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports 2:337–350. https://doi.org/10.1016/J.STEMCR.2014.01.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/J.STEMCR.2014.01.013</ArticleId>
            <ArticleId IdType="pubmed">24672756</ArticleId>
            <ArticleId IdType="pmc">3964289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imaizumi K, Sone T, Ibata K et al (2015) Controlling the regional identity of hPSC-derived neurons to uncover neuronal subtype specificity of neurological disease phenotypes. Stem Cell Reports 5:1010–1022. https://doi.org/10.1016/j.stemcr.2015.10.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stemcr.2015.10.005</ArticleId>
            <ArticleId IdType="pubmed">26549851</ArticleId>
            <ArticleId IdType="pmc">4682123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki S, Akamatsu W, Kisa F et al (2017) Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons. Biochem Biophys Res Commun 483:88–93. https://doi.org/10.1016/j.bbrc.2016.12.188</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2016.12.188</ArticleId>
            <ArticleId IdType="pubmed">28057485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valentine MNZ, Hashimoto K, Fukuhara T et al (2019) Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson’s disease. Sci Data 6:20. https://doi.org/10.1038/s41597-019-0022-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41597-019-0022-9</ArticleId>
            <ArticleId IdType="pubmed">30952910</ArticleId>
            <ArticleId IdType="pmc">6472336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ikeda A, Nishioka K, Meng H et al (2019) Mutations in CHCHD2 cause α-synuclein aggregation. Hum Mol Genet 28:3895–3911. https://doi.org/10.1093/hmg/ddz241</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddz241</ArticleId>
            <ArticleId IdType="pubmed">31600778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oji Y, Hatano T, Ueno S-I et al (2020) Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease. Brain 143:1190–1205. https://doi.org/10.1093/brain/awaa064</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awaa064</ArticleId>
            <ArticleId IdType="pubmed">32201884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiba-Fukushima K, Ishikawa K-I, Inoshita T et al (2017) Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson’s disease. Hum Mol Genet 26:3172–3185. https://doi.org/10.1093/hmg/ddx201</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddx201</ArticleId>
            <ArticleId IdType="pubmed">28541509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren Q, Ma M, Yang J et al (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson’s disease. Proc Natl Acad Sci U S A 115:E5815–E5823. https://doi.org/10.1073/pnas.1802179115</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1802179115</ArticleId>
            <ArticleId IdType="pubmed">29735655</ArticleId>
            <ArticleId IdType="pmc">6016799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirano K, Fujimaki M, Sasazawa Y et al (2019) Neuroprotective effects of memantine via enhancement of autophagy. Biochem Biophys Res Commun 518:161–170. https://doi.org/10.1016/j.bbrc.2019.08.025</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2019.08.025</ArticleId>
            <ArticleId IdType="pubmed">31431260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kataura T, Saiki S, Ishikawa K-I et al (2020) BRUP-1, an intracellular bilirubin modulator, exerts neuroprotective activity in a cellular Parkinson’s disease model. J Neurochem 155(1):81–97. https://doi.org/10.1111/jnc.14997</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jnc.14997</ArticleId>
            <ArticleId IdType="pubmed">32128811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiba-Fukushima K, Inoshita T, Sano O et al (2020) A cell-based high-throughput screening identified two compounds that enhance PINK1-Parkin signaling. iScience 23:101048. https://doi.org/10.1016/j.isci.2020.101048</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.isci.2020.101048</ArticleId>
            <ArticleId IdType="pubmed">32335362</ArticleId>
            <ArticleId IdType="pmc">7183160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamaguchi A, Ishikawa K-I, Inoshita T et al (2020) Identifying therapeutic agents for amelioration of mitochondrial clearance disorder in neurons of familial Parkinson disease. Stem Cell Reports 14:1060–1075. https://doi.org/10.1016/j.stemcr.2020.04.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stemcr.2020.04.011</ArticleId>
            <ArticleId IdType="pubmed">32470327</ArticleId>
            <ArticleId IdType="pmc">7355139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohnuki M, Takahashi K, Yamanaka S (2009) Generation and characterization of human induced pluripotent stem cells. Curr Protoc Stem Cell Biol 9:4A.2.1–4A.2.25. https://doi.org/10.1002/9780470151808.sc04a02s9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/9780470151808.sc04a02s9</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
